학술논문

ZYZ384 suppresses the growth of EGFR-mutant non-small cell lung cancer by activating JNK/MAPK signaling pathway
Document Type
Article
Source
In: Chemical Biology and Drug Design. (Chemical Biology and Drug Design, January 2024, 103(1))
Subject
Language
English
ISSN
17470285
17470277